Sign Up to like & get
recommendations!
1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.37606
Abstract: Key Points Question What is the comparative risk of cardiovascular outcomes associated with empagliflozin vs liraglutide or sitagliptin, overall and across strata of age, sex, baseline atherosclerotic cardiovascular diseases, heart failure, and chronic kidney disease?…
read more here.
Keywords:
liraglutide sitagliptin;
empagliflozin liraglutide;
older adults;
risk ... See more keywords